S. Charles Schulz, MD
- 7Articles
- 26.1KReads
- 1998–2016Active
- 30Collaborators
- 128Citations
About
S. Charles Schulz, MD, has contributed extensively to the study of schizophrenia, schizoaffective disorders, and mood disorders, with publications spanning from 1998 to 2016. His work includes investigations into cognitive impairment in schizophrenia, pharmacologic treatment options, and clinical evaluations of antipsychotic medications such as olanzapine and quetiapine. Schulz has also explored treatment outcomes in adolescents with schizophrenia and the use of lithium augmentation in poorly responsive patients.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
